✦ LIBER ✦

Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease

✍ Scribed by Q. Gao; R. A. van Hogezand; C. B. H. W. Lamers; H. W. Verspaget

Book ID: 108603744
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 234 KB
Volume: 20
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2004.02126.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab downregulates basic fibroblas

Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients

✍ A. Di Sabatino; R. Ciccocioppo; L. Benazzato; G. C. Sturniolo; G. R. Corazza 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Peripheral regulatory T cells and serum

Peripheral regulatory T cells and serum transforming growth factor-β: Relationship with clinical response to infliximab in Crohn's disease

✍ Antonio Di Sabatino; Paolo Biancheri; Silvia Piconese; M. Manuela Rosado; Sandro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 745 KB

Background: CD4 þ Foxp3 þ regulatory T cells (Treg) inhibit Tcell proliferation in vitro and are effective in suppressing colitis in mouse models. Tumor necrosis factor (TNF)-a, which is centrally involved in Crohn's disease (CD) pathogenesis, also impairs Treg function. Here we investigated the inf

Genetic polymorphisms of tumour necrosis

Genetic polymorphisms of tumour necrosis factor receptor superfamily 1A and 1B affect responses to infliximab in Japanese patients with Crohn’s disease

✍ H. MATSUKURA; S. IKEDA; N. YOSHIMURA; M. TAKAZOE; M. MURAMATSU 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Basic fibroblast growth factor as a medi

Basic fibroblast growth factor as a mediator of the effects of glutamate in the development of long-lasting sensitization to stimulant drugs: studies in the rat

✍ C. Flores; J. Stewart 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 149 KB